Cancer Manag Res. 2015 Sep 11;7:291-9. doi: 10.2147/CMAR.S34859. eCollection 2015.
Targeting autophagy in cancer management - strategies and developments.
Cancer management and research
Bulent Ozpolat, Doris M Benbrook
Affiliations
Affiliations
- Department of Experimental Therapeutics, The University of Texas - Houston, MD Anderson Cancer Center, Houston, TX, USA.
- Department of Obstetrics and Gynecology, University of Oklahoma HSC, Oklahoma City, OK, USA.
PMID: 26392787
PMCID: PMC4573074 DOI: 10.2147/CMAR.S34859
Abstract
Autophagy is a highly regulated catabolic process involving lysosomal degradation of intracellular components, damaged organelles, misfolded proteins, and toxic aggregates, reducing oxidative stress and protecting cells from damage. The process is also induced in response to various conditions, including nutrient deprivation, metabolic stress, hypoxia, anticancer therapeutics, and radiation therapy to adapt cellular conditions for survival. Autophagy can function as a tumor suppressor mechanism in normal cells and dysregulation of this process (ie, monoallelic Beclin-1 deletion) may lead to malignant transformation and carcinogenesis. In tumors, autophagy is thought to promote tumor growth and progression by helping cells to adapt and survive in metabolically-challenged and harsh tumor microenvironments (ie, hypoxia and acidity). Recent in vitro and in vivo studies in preclinical models suggested that modulation of autophagy can be used as a therapeutic modality to enhance the efficacy of conventional therapies, including chemo and radiation therapy. Currently, more than 30 clinical trials are investigating the effects of autophagy inhibition in combination with cytotoxic chemotherapies and targeted agents in various cancers. In this review, we will discuss the role, molecular mechanism, and regulation of autophagy, while targeting this process as a novel therapeutic modality, in various cancers.
Keywords: autophagy inhibition; chemotherapy; tumor microenvironment
References
- Int J Biochem Cell Biol. 2004 Dec;36(12):2491-502 - PubMed
- Autophagy. 2008 Jul;4(5):669-79 - PubMed
- Nat Rev Mol Cell Biol. 2014 Mar;15(3):153 - PubMed
- Cell Tissue Res. 2002 Sep;309(3):409-16 - PubMed
- Cancer Res. 2001 Jan 15;61(2):439-44 - PubMed
- Cancer Cell. 2003 Dec;4(6):422-4 - PubMed
- Hum Mol Genet. 2006 Oct 1;15(19):2962-71 - PubMed
- Cell Death Differ. 2004 Apr;11(4):448-57 - PubMed
- Mol Cell Biol. 2005 Feb;25(3):1025-40 - PubMed
- J Pathol. 2012 Dec;228(4):437-47 - PubMed
- Hematol Oncol Stem Cell Ther. 2013 Mar;6(1):20-5 - PubMed
- Genes Dev. 2007 Jul 1;21(13):1621-35 - PubMed
- Autophagy. 2014 Aug;10 (8):1369-79 - PubMed
- Mol Ther Nucleic Acids. 2013 Sep 10;2:e121 - PubMed
- Cell Death Differ. 2007 Mar;14 (3):548-58 - PubMed
- Autophagy. 2011 Nov;7(11):1371-8 - PubMed
- J Cell Sci. 2006 Feb 15;119(Pt 4):605-14 - PubMed
- Breast Cancer Res Treat. 2008 Dec;112(3):389-403 - PubMed
- Blood. 2007 Jul 1;110(1):313-22 - PubMed
- Cancer Res. 2008 Mar 1;68(5):1485-94 - PubMed
- Autophagy. 2014 Aug;10(8):1415-25 - PubMed
- Curr Biol. 2012 Jan 10;22(1):R29-34 - PubMed
- Autophagy. 2014 Aug;10(8):1403-14 - PubMed
- Radiat Oncol. 2013 Sep 08;8:209 - PubMed
- Ann Intern Med. 2006 Mar 7;144(5):337-43 - PubMed
- J Pathol. 2007 Jan;211(2):134-43 - PubMed
- Cell Death Differ. 2013 Jan;20(1):31-42 - PubMed
- Clin Cancer Res. 2012 Jan 15;18(2):370-9 - PubMed
- J Biol Chem. 2000 Jan 14;275(2):992-8 - PubMed
- J Biol Chem. 2008 Mar 14;283(11):6783-9 - PubMed
- Trends Biochem Sci. 2007 Jan;32(1):37-43 - PubMed
- Autophagy. 2007 Jan-Feb;3(1):72-4 - PubMed
- Curr Biol. 2007 Jan 9;17 (1):1-11 - PubMed
- Cancer Res. 2001 Apr 15;61(8):3443-9 - PubMed
- Am J Cancer Res. 2012;2(4):397-413 - PubMed
- Cancer Res. 1995 Mar 1;55(5):1002-5 - PubMed
- Cell. 2005 Sep 23;122(6):927-39 - PubMed
- J Clin Invest. 2003 Dec;112(12 ):1809-20 - PubMed
- Annu Rev Pharmacol Toxicol. 2012;52:381-400 - PubMed
- Autophagy. 2014 Aug;10(8):1380-90 - PubMed
- J Biol Chem. 2001 Sep 21;276(38):35243-6 - PubMed
- Nat Rev Cancer. 2005 Sep;5(9):726-34 - PubMed
- Curr Mol Med. 2009 May;9(4):417-24 - PubMed
- Genes Dev. 2011 Mar 1;25(5):460-70 - PubMed
- J Clin Invest. 2008 Dec;118(12):3917-29 - PubMed
- Nat Rev Cancer. 2005 Nov;5(11):886-97 - PubMed
- Oncogene. 2007 Jun 14;26(28):4071-83 - PubMed
- Genes Dev. 2013 Jul 1;27(13):1447-61 - PubMed
- Biochim Biophys Acta. 2003 Mar 17;1603(2):113-28 - PubMed
- FEBS Lett. 2010 Apr 2;584(7):1287-95 - PubMed
- Curr Biol. 2005 Aug 23;15(16):1513-7 - PubMed
- PLoS One. 2013;8(1):e55096 - PubMed
- J Biol Chem. 2003 May 9;278(19):16667-74 - PubMed
- Autophagy. 2012 Apr;8(4):445-544 - PubMed
- Annu Rev Cell Dev Biol. 2011;27:107-32 - PubMed
- Autophagy. 2010 Apr;6(3):322-9 - PubMed
- Neurobiol Dis. 2007 Feb;25(2):252-65 - PubMed
- Invest Ophthalmol Vis Sci. 2010 Nov;51(11):6030-7 - PubMed
- Nature. 1999 Dec 9;402(6762):672-6 - PubMed
- Proc Natl Acad Sci U S A. 2005 Oct 4;102(40):14132-8 - PubMed
- Cell Mol Life Sci. 2012 Apr;69(7):1125-36 - PubMed
- Cancer Res. 2005 Apr 15;65(8):3336-46 - PubMed
- Autophagy. 2007 Sep-Oct;3(5):480-3 - PubMed
- Nat Cell Biol. 2010 Sep;12(9):814-22 - PubMed
- J Biol Chem. 2012 Jun 1;287(23):19094-104 - PubMed
- Cell. 2008 Jan 11;132(1):27-42 - PubMed
- Cancer Res. 1993 Jul 15;53(14):3382-5 - PubMed
- Oncogene. 2012 Feb 23;31(8):939-53 - PubMed
- Autophagy. 2014 Aug;10 (8):1359-68 - PubMed
- Cell Death Differ. 2007 Mar;14(3):500-10 - PubMed
- Autophagy. 2014 Aug;10(8):1391-402 - PubMed
- J Clin Invest. 2007 Feb;117(2):326-36 - PubMed
- Drug Resist Updat. 2010 Jun;13(3):87-92 - PubMed
Publication Types